Opendata, web and dolomites

uCARE SIGNED

Understanding Circumventing Antibiotic REsistance

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 uCARE project word cloud

Explore the words cloud of the uCARE project. It provides you a very rough idea of what is the project "uCARE" about.

uncover    full    identification    preliminary    line    combinations    diseases    tens    policies    antimicrobial    genetic    antidotes    microbes    therapies    possibly    counteract    spread    resistance    again    direct    principles    repertoire    mechanisms    severity    prevent    deadly    genetics    health    issue    public    networks    antibiotics    treatable    data    it    paths    proof    once    250    reverting    driver    drug    cross    hitherto    drivers    thermal    polypharmacy    cellular    living    delay    bacterial    heels    expose    elucidate    drugs    chemical    utmost    biological    equally    achilles    broad    proteome    antibacterial    imperative    indicate    action    systematically    revisiting    throughput    underlying    revert    fundamental    longer    undermining    map    unnoticed    reverse    experimental    basis    ways    antibiotic    yield    implies    human    seek    bacteria    gut    mode    medication    evolution    standards    candidates    lived    profiling   

Project "uCARE" data sheet

The following table provides information about the project.

Coordinator
EUROPEAN MOLECULAR BIOLOGY LABORATORY 

Organization address
address: Meyerhofstrasse 1
city: HEIDELBERG
postcode: 69117
website: http://www.embl.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙986˙004 €
 EC max contribution 1˙986˙004 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-COG
 Funding Scheme ERC-COG
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2024-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EUROPEAN MOLECULAR BIOLOGY LABORATORY DE (HEIDELBERG) coordinator 1˙986˙004.00

Map

 Project objective

The evolution and spread of antibiotic resistance has become a public health concern of the utmost severity, making once treatable diseases deadly again and undermining our living standards. New therapies are imperative, but equally important are the understanding of the full repertoire of drivers of antibiotic resistance and the identification of ways to counteract them. We have recently established that ~250 non-antibiotic drugs have direct, strong and often broad antibacterial effects on human gut microbes. Moreover, preliminary data indicate that bacteria use similar general resistance mechanisms against both drugs with human targets and antibiotics. This implies that polypharmacy may be a hitherto unnoticed driver of antibiotic resistance. We will use chemical genetics and experimental evolution to systematically map the cross-resistance between human-targeted drugs and antibiotics, and elucidate underlying resistance mechanisms. Using these data, we will next seek to identify antidotes for the antimicrobial side-effects of non-antibiotic drugs, and exploit human-targeted drugs for reverting existing antibiotic resistance. At the genetic level, we will use high-throughput reverse genetics to expose the Achilles heels of bacterial cellular networks for resistance development. Finally, we will uncover the antimicrobial mode of action of tens of human-targeted drugs using thermal proteome profiling and chemical genetics. Together with the genetic information, this line of research will yield design principles and possibly new drug candidates for longer-lived, resistance-proof drug combinations. Overall, this project aims at improving our fundamental biological understanding of antibiotic resistance and the paths to prevent, delay or revert it. It can also set the basis for revisiting current medication policies. The derived principles are likely to be relevant to other diseases and therapies, in which resistance development is an issue.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UCARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UCARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

RECON (2019)

Reprogramming Conformation by Fluorination: Exploring New Areas of Chemical Space

Read More  

DISSECT (2020)

DISSECT: Evidence in International Human Rights Adjudication

Read More  

HYDROGEN (2019)

HighlY performing proton exchange membrane water electrolysers with reinforceD membRanes fOr efficient hydrogen GENeration

Read More